{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:22:52Z","timestamp":1778718172337,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.vaccine.2004.10.025","type":"journal-article","created":{"date-parts":[[2004,12,12]],"date-time":"2004-12-12T00:47:20Z","timestamp":1102812440000},"page":"1957-1965","source":"Crossref","is-referenced-by-count":43,"title":["Effect of homologous and heterologous prime\u2013boost on the immune response to recombinant plague antigens"],"prefix":"10.1016","volume":"23","author":[{"given":"Audrey","family":"Glynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy C.","family":"Freytag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2004.10.025_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2004.10.025_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0264-410X(00)00108-0","article-title":"Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains","volume":"19","author":"Jones","year":"2000","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2004.10.025_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1\u2013V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.vaccine.2004.10.025_bib4","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.10.025_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2004.10.025_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2004.10.025_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2004.10.025_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.10.025_bib9","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/IAI.72.4.2052-2056.2004","article-title":"Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague","volume":"72","author":"Jarrett","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2004.10.025_bib10","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.4049\/jimmunol.165.11.6454","article-title":"Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL","volume":"165","author":"Belyakov","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.10.025_bib11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/IAI.67.2.826-833.1999","article-title":"Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis","volume":"67","author":"C\u00e1rdenas-Freytag","year":"1999","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2004.10.025_bib12","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1128\/JVI.73.9.7574-7581.1999","article-title":"Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein","volume":"73","author":"Choi","year":"1999","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2004.10.025_bib13","doi-asserted-by":"crossref","first-page":"11574","DOI":"10.1128\/JVI.74.24.11574-11580.2000","article-title":"Functional mapping of protective domains and epitopes in the rotavirus VP6 protein","volume":"74","author":"Choi","year":"2000","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.10.025_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0264-410X(97)00255-7","article-title":"LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.","volume":"16","author":"Chong","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.10.025_bib15","first-page":"215","article-title":"Bacterial toxins as mucosal adjuvants","volume":"236","author":"Freytag","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2004.10.025_bib16","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/JVI.75.10.4752-4760.2001","article-title":"Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA","volume":"75","author":"Gerber","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.10.025_bib17","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1128\/IAI.68.7.4349-4353.2000","article-title":"Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain","volume":"68","author":"Guillobel","year":"2000","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.10.025_bib18","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2004.10.025_bib19","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1128\/IAI.67.11.5799-5805.1999","article-title":"Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni","volume":"67","author":"Lee","year":"1999","journal-title":"Infect Immun"},{"issue":"27","key":"10.1016\/j.vaccine.2004.10.025_bib20","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/S0264-410X(01)00088-3","article-title":"Mucosal immunization of mice using CpG DNA and\/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants","volume":"19","author":"McCluskie","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2004.10.025_bib21","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1128\/JVI.73.9.7565-7573.1999","article-title":"Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles","volume":"73","author":"McNeal","year":"1999","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2004.10.025_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0264-410X(99)00447-8","article-title":"Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 Env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)","volume":"18","author":"Morris","year":"1944","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2004.10.025_bib23","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/JVI.72.4.3390-3393.1998","article-title":"Rotavirus 2\/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge","volume":"72","author":"O\u2019Neal","year":"1998","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.10.025_bib24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/IAI.67.4.1694-1701.1999","article-title":"In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae","volume":"67","author":"Ryan","year":"1999","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2004.10.025_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-2427(99)00074-4","article-title":"Active immunity and T-cell populations in pigs intraperitoneally inoculated with baculovirus-expressed transmissible gastroenteritis virus structural proteins","volume":"70","author":"Sestak","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.vaccine.2004.10.025_bib26","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1128\/IAI.68.9.5306-5313.2000","article-title":"Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants","volume":"68","author":"Scharton-Kersten","year":"2000","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2004.10.025_bib27","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2004.10.025_bib28","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1128\/JVI.74.19.8843-8853.2000","article-title":"Intranasal administration of 2\/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs","volume":"74","author":"Yuan","year":"2000","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.10.025_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0264-410X(99)00168-1","article-title":"The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)","volume":"18","author":"Cheng","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.10.025_bib30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/IAI.67.3.1100-1106.1999","article-title":"Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants","volume":"67","author":"Glenn","year":"1999","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2004.10.025_bib31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/82225","article-title":"Transcutaneous immunization: a human vaccine delivery strategy using a patch","volume":"6","author":"Glenn","year":"2000","journal-title":"Nature Med"},{"issue":"9","key":"10.1016\/j.vaccine.2004.10.025_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0161-5890(00)00074-2","article-title":"Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract","volume":"37","author":"Gockel","year":"2000","journal-title":"Mol Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2004.10.025_bib33","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1128\/JVI.78.14.7610-7618.2004","article-title":"Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice","volume":"78","author":"Guebre-Xabier","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.10.025_bib34","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/IAI.70.4.1874-1880.2002","article-title":"Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously","volume":"70","author":"Guerena-Burgueno","year":"2002","journal-title":"Infect Immun"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2004.10.025_bib35","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/S0264-410X(02)00119-6","article-title":"Determination of the virulence of the pigmentation-deficient and pigmentation-\/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague","volume":"20","author":"Welkos","year":"2002","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2004.10.025_bib36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine. USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.10.025_bib37","first-page":"14","article-title":"Study of PGM mutation mechanism in Yersinia pestis (plague pathogen) vaccine strain EV76","author":"Podladchikova","year":"2002","journal-title":"Mol Gen Mikrobiol Virusol"},{"issue":"21","key":"10.1016\/j.vaccine.2004.10.025_bib38","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0264-410X(00)00019-0","article-title":"Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses","volume":"18","author":"Baca-Estrada","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.10.025_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/IAI.72.2.908-915.2004","article-title":"Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates","volume":"72","author":"Flashner","year":"2004","journal-title":"Infect Immun"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2004.10.025_bib40","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/S0264-410X(03)00112-9","article-title":"Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague","volume":"21","author":"Garmory","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2004.10.025_bib41","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1128\/IAI.71.7.3831-3836.2003","article-title":"Salmonella enterica serovar Typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge","volume":"71","author":"Garmory","year":"2003","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2004.10.025_bib42","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.vaccine.2004.01.007","article-title":"A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice","volume":"22","author":"Morton","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.10.025_bib43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2004.10.025_bib44","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1365-2672.2001.01497.x","article-title":"Plague vaccine research and development","volume":"91","author":"Williamson","year":"2001","journal-title":"J Appl Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2004.10.025_bib45","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated sub-unit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2004.10.025_bib46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2004.10.025_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mpat.2000.0385","article-title":"The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses","volume":"29","author":"Elvin","year":"2000","journal-title":"Microb Pathog"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2004.10.025_bib48","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0264-410X(02)00687-4","article-title":"Improvement of the systemic prime\/oral boost strategy for systemic and local responses","volume":"21","author":"Lauterslager","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.10.025_bib49","first-page":"305","article-title":"The effects of oral and combined parenteral\/oral immunization against an experimental Escherichia coli urinary tract infection in mice","volume":"54","author":"Layton","year":"1983","journal-title":"Clin Exp Immunol"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2004.10.025_bib50","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0264-410X(03)00054-9","article-title":"Effect of priming\/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct","volume":"21","author":"Nicholas","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2004.10.025_bib51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/infdis\/135.6.888","article-title":"Immunity to experimental cholera III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs","volume":"135","author":"Pierce","year":"1977","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2004.10.025_bib52","first-page":"404","article-title":"Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization","volume":"66","author":"Van der Heijden","year":"1989","journal-title":"Immunology"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2004.10.025_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0264-410X(02)00407-3","article-title":"Memory T cells and vaccines","volume":"21","author":"Esser","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T17:29:00Z","timestamp":1586021340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04008151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":53,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0264410X04008151"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.10.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}